It's time for another NephJC draft! This time the 2024 KDIGO CKD guideline draft is on the clock! Results of Nefecon (budesonide) for IgA nephropathy set the stage for a glomerulonephritis renaissance. Vlado Perkovic presented results from the FLOW trial at the 61st ERA Congress, making headlines worldwide. A blood test may help nephrologists answer the question, “Is this preeclampsia, proteinuric CKD, or a lupus flare?” Will sparsentan prove a winner for patients with FSGS, or are we doomed to forever treat them with Acthar Gel? We've all been guilted into ordering inpatient blood pressure meds. Tim Anderson, MD, asks, "Why?" What can the Gila monster and mourning dove teach us about comparative nephrology?